The focus of the event will be requirements for generic drug registration and how pharmaceutical companies can achieve quality compliance on dossier submission.
The conference shall focus on the common deficiencies of product dossiers that affect the registration process of pharmaceutical products and seek for better compliance towards the requirements in order to ease dossier review process for NPRA officers.